Investor Stock List
Ranked #1,677 of 8,699 institutional investors

Caligan Partners LP

New York, NY

$1.71B
US stock portfolio at live prices · today −$8.0M (−0.46%)
Market closed. Prices as of Nov 20, 9:11 AM ET
Value at quarter end (Q3 2026)
$1.63B
Change from Q2 2026
−$438.6M (−21.16%)
Positions
25 · 2 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$2.5M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
LQDA 26.9%RVMD 18.3%PCVX 7.47%ABVX 7.35%EXEL 5.98%
StockSharesValue, live% of portfoliovs Q2 2026
LQDA Liquidia Corporation8,118,892$460M26.9%Unchanged
RVMD Revolution Medicines, Inc.1,961,795$313M18.3%Unchanged
PCVX Vaxcyte, Inc.2,188,636$128M7.47%Unchanged
ABVX ABIVAX Société Anonyme1,557,924$126M7.35%Unchanged
EXEL Exelixis, Inc.1,553,262$102M5.98%Unchanged
ADMA ADMA Biologics, Inc.5,875,007$78.4M4.59%Added +3%
VRDN Viridian Therapeutics, Inc.2,193,981$69.0M4.04%Unchanged
LBRX LB Pharmaceuticals Inc1,509,621$60.4M3.54%Added +5%
TNGX Tango Therapeutics, Inc.2,501,246$56.8M3.32%Unchanged
IMCR Immunocore Holdings plc1,672,141$44.5M2.61%Added +21%
VOR Vor Biopharma Inc.1,925,066$35.7M2.09%Unchanged
AURA Aura Biosciences, Inc.4,590,253$32.0M1.87%Added +7%
IVA Inventiva S.A.9,185,935$31.7M1.85%Added +13%
SGMT Sagimet Biosciences Inc.2,794,484$26.9M1.57%Added +12%
SABS SAB Biotherapeutics, Inc.8,736,898$25.4M1.49%Added +10%
IRD Opus Genetics, Inc.5,960,972$24.3M1.42%Reduced −2%
AVTX Avalo Therapeutics, Inc.3,268,303$22.1M1.29%Added +3%
ANIK Anika Therapeutics, Inc.1,435,130$19.1M1.12%Unchanged
TYRA Tyra Biosciences, Inc.910,749$18.0M1.05%Added +13%
OBX Obsidian Therapeutics, Inc.886,281$10.8M0.63%New
FTH Faeth Therapeutics, Inc.890,210$7.7M0.45%Added +41%
EPRX Eupraxia Pharmaceuticals Inc.1,163,010$7.1M0.42%New
ARTV Artiva Biotherapeutics, Inc.1,481,043$5.7M0.33%Reduced −15%
VRCA Verrica Pharmaceuticals Inc.923,910$2.7M0.16%Unchanged
CLRB Cellectar Biosciences, Inc.469,998$415K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
XENE Xenon Pharmaceuticals Inc.889,944$33.4M
MBX MBX Biosciences, Inc.200,000$10.7M